Australia Markets closed

Why this ASX cannabis stock slumped 30% this morning

Kenneth Hall
Legalise Marijuana

Shares in ASX cannabis stock Creso Pharma Ltd (ASX: CPH) have plummeted 30% lower in early trade after emerging from a month-long trading halt.

Why did Creso Pharma enter a trading halt?

The ASX cannabis stock entered a trading halt on 1 November as it sought additional debt and equity capital from investors.

Creso Pharma subsequently rejected a takeover proposal from PharmaCielo Ltd announced on 7 June 2019.

The Scheme Implementation Agreement was terminated on 11 November after a new Independent Expert said the takeover was neither fair nor reasonable and not in the best interests of Creso Pharma shareholders.

Creso Pharma was required to repay the outstanding CDN$3.9 million loans advanced by PharmaCielo by 30 November 2019.

Why is the ASX cannabis stock in freefall?

The ASX cannabis stock plummeted nearly 30% lower at the market open this morning as Creso Pharma shares traded for the first time since 1 November.

Creso released an operational and strategic update to the market this morning. The ASX cannabis group has secured funding to accelerate its global operations with a narrower focus, raising $5.03 million through a $3.45 million issue of convertible securities and a $1.58 million share placement.

The pharmaceuticals company has the ability to raise a further $2.05 million from its additional First Tranche notes.

The group’s $0.191 per share raising price was a steep discount on its $0.21 closing price on 1 November. Investors have sold down the company’s shares in early trade to as low as $0.14 per share this morning.

Creso Pharma is looking to increase revenue from nutraceuticals and animal health products as part of its renewed strategy. The ASX cannabis group expects to generate more than $3.6 million in revenue in CY 2019 from the segment.

Cost management was highlighted as a priority as Creso Pharma looks to reduce its monthly cash burn.

The group’s shares recovered briefly but are trading 26.83% down at $0.15 per share at the time of writing.

The post Why this ASX cannabis stock slumped 30% this morning appeared first on Motley Fool Australia.

If you're after more ASX dividends stocks in December then check out these 3 potential winners below.

Top 3 Dividend Shares To Buy For 2020

When Edward Vesely -- our resident dividend expert -- has a stock tip, it can pay to listen. With huge winners like Dicker Data (up 147%) and Collins Food (up 105%) under his belt, Edward is building an enviable following amongst investors that are planning for retirement.

In a brand new report, Edward has just revealed what he believes are the 3 best dividend stocks for income-hungry investors to buy now. All 3 stocks are paying growing fully franked dividends giving you the opportunity to combine capital appreciation with attractive dividend yields.

Best of all, Edward’s “Top 3 Dividend Shares To Buy For 2020” report is totally free to all Motley Fool readers.

Click here now to access this free report.

More reading

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019